2-BroMo-3-(thiazol-2-yloxy)-pyridine, 98+% C8H5BrN2OS, MW: 257.11
|
- $482 - $497.2
- Product name: 2-BroMo-3-(thiazol-2-yloxy)-pyridine, 98+% C8H5BrN2OS, MW: 257.11
- CAS: 1065484-74-3
- MF: C8H5BrN2OS
- MW: 257.11
- EINECS:
- MDL Number:MFCD10698952
- Synonyms:2-BroMo-3-(thiazol-2-yloxy)-pyridine, 98+% C8H5BrN2OS, MW: 257.11;2-Bromo-3-(2-thiazolyloxy)pyridine;2-((2-BROMOPYRIDIN-3-YL)OXY)THIAZOLE;Pyridine, 2-bromo-3-(2-thiazolyloxy)-
4 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Crysdot
Package
- 5MG
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0295016
- Product description2-BROMO-3-(THIAZOL-2-YLOXY)-PYRIDINE 95.00%
- Packaging5MG
- Price$497.2
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11357359
- Product description2-((2-Bromopyridin-3-yl)oxy)thiazole 95+%
- Packaging1g
- Price$482
- Updated2026-05-27
- Buy
- ManufacturerCrysdot
- Product numberCD11357359
- Product description2-((2-Bromopyridin-3-yl)oxy)thiazole 95+%
- Packaging1g
- Price$482
- Updated2026-05-20
- Buy
- ManufacturerCrysdot
- Product numberCD11357359
- Product description2-((2-Bromopyridin-3-yl)oxy)thiazole 95+%
- Packaging1g
- Price$482
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | HCH0295016 | 2-BROMO-3-(THIAZOL-2-YLOXY)-PYRIDINE 95.00% | 5MG | $497.2 | 2021-12-16 | Buy |
| Crysdot | CD11357359 | 2-((2-Bromopyridin-3-yl)oxy)thiazole 95+% | 1g | $482 | 2026-05-27 | Buy |
| Crysdot | CD11357359 | 2-((2-Bromopyridin-3-yl)oxy)thiazole 95+% | 1g | $482 | 2026-05-20 | Buy |
| Crysdot | CD11357359 | 2-((2-Bromopyridin-3-yl)oxy)thiazole 95+% | 1g | $482 | 2021-12-16 | Buy |
Properties
Boiling point :366.0±52.0 °C(Predicted)
Density :1.690
pka :0.90±0.10(Predicted)
Density :1.690
pka :0.90±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|